Acute liver failure after vaccination against of COVID-19; a case report and review literature

Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design

(2021) Xuhua Xia   Viruses-Basel

COVID-19 and liver disease: mechanistic and clinical perspectives

(2021) Thomas Marjot et al.   Nature Reviews Gastroenterology & Hepatology

Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine

(2021) Ruth A. Karron et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

(2021) Nina H. Schultz et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

(2021) Douglas B. Cines et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

(2021) Andreas Greinacher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

(2020) Dorothea Bestle et al.   Life Science Alliance

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

(2020) Maheshi N Ramasamy et al.   LANCET

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review

(2019) Theodore E. Warkentin   Expert Review of Hematology

Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia

(2018) Mehraboon Irani et al.   TRANSFUSION

Autoimmune heparin-induced thrombocytopenia

(2017) A. Greinacher et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS